| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B Lelongt, G Trugnan, G Murphy, P M Ronc. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. The Journal of cell biology. vol 136. issue 6. 1997-05-06. PMID:9087449. |
matrix metalloproteinases mmp2 and mmp9 are produced in early stages of kidney morphogenesis but only mmp9 is required for renal organogenesis in vitro. |
1997-05-06 |
2023-08-12 |
mouse |
| Y Soini, E Alarakkola, H Autio-Harmaine. Expression of messenger RNAs for metalloproteinases 2 and 9, type IV collagen, and laminin in nonneoplastic and neoplastic endometrium. Human pathology. vol 28. issue 2. 1997-03-06. PMID:9023406. |
the presence of mmp2, laminin, and iv collagen mrna in normal endometrium reflects their importance in the tissue response and matrix remodeling during the proliferative and secretory phases of the menstrual cycle. |
1997-03-06 |
2023-08-12 |
Not clear |
| T Yudate, K Isaka, Y Kosugi, M Koshiishi, K Shiraishi, M Hosaka, M Takayam. [Analysis of the mechanism of trophoblast infiltration]. Nihon Sanka Fujinka Gakkai zasshi. vol 48. issue 3. 1996-09-19. PMID:8721053. |
the expression of matrix metalloproteinase 2 (mmp2) and matrix metalloproteinase 9 (mmp9), which deeply involve infiltrative metastasis of cancer, and the reactivity to transforming growth factor beta 1 (tgf beta 1), which controls the expression of these mmps and inhibits the growth of epithelial cells, were investigated in ct derived from villi at normal gestational week 6 (early ct) and ct derived from villi at normal gestational week 37 (full-term ct), and also the choriocarcinoma cell line bewo (bewo). |
1996-09-19 |
2023-08-12 |
Not clear |
| T Yudate, K Isaka, Y Kosugi, M Koshiishi, K Shiraishi, M Hosaka, M Takayam. [Analysis of the mechanism of trophoblast infiltration]. Nihon Sanka Fujinka Gakkai zasshi. vol 48. issue 3. 1996-09-19. PMID:8721053. |
in uterine stroma-derived cells, membrane type matrix metalloproteinase (mt-mmp), which activates mmp2, was observed. |
1996-09-19 |
2023-08-12 |
Not clear |
| E Levi, R Fridman, H Q Miao, Y S Ma, A Yayon, I Vlodavsk. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proceedings of the National Academy of Sciences of the United States of America. vol 93. issue 14. 1996-08-29. PMID:8692946. |
here we report that the 72-kda gelatinase a (matrix metalloproteinase type 2, mmp2) can hydrolyze the val368-met369 peptide bond of the fgfr1 ectodomain, eight amino acids upstream of the transmembrane domain, thus releasing the entire extracellular domain. |
1996-08-29 |
2023-08-12 |
Not clear |
| C Clavel, M Polette, M Doco, I Binninger, P Birembau. Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology. Bulletin du cancer. vol 79. issue 3. 1992-11-12. PMID:1392165. |
the distribution of 3 major matrix metallo-proteinases was studied in human mammary pathology: collagenase (mmp1) which degrades fibrillar interstitial collagens, a 72-kda gelatinase (mmp2) which mainly degrades type iv collagen and denatured collagens, and stromelysin (mmp3) which has a wider range of action, degrading several matrix components including the core proteins of proteoglycans, laminin and non-helical regions of collagens. |
1992-11-12 |
2023-08-11 |
human |